D68.32
Hemorrhagic disorder due to extrinsic circulating anticoagulants
HCC risk adjustment mapping
CMS-HCC ESRD V24
Coagulation Defects and Other Specified Hematological Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D68.32
FY 2026 ›Find D68.32 in the alphabetic index
9 index paths lead to this code
- Hyperheparinemia
- Anticoagulant, circulating › drug-induced
- Anticoagulant, circulating › iatrogenic
- Circulating anticoagulants › due to drugs
- Disorder › drug induced hemorrhagic
- Disorder › hemorrhagic NEC › drug-induced
- Disorder › hemorrhagic NEC › due to › extrinsic circulating anticoagulants
- Disorder › hemorrhagic NEC › due to › increase in › anti-IIa
- Disorder › hemorrhagic NEC › due to › increase in › anti-Xa